PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES) [PDF]
Acta Medica Iranica, 1986 Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY +1 more
doaj +1 more source
Electrophysiological Parameters of Sinus Node Function in Patients with Paroxysmal Tachyarrhythmias [PDF]
, 2018 to analyze the indicators of the function of the sinus node in patients of young age with paroxysmal tachycardia. Methods: study included 11 patients with suspected paroxysmal tachycardia, with an average age of 17±28.
Balykova, L A +5 more
core +2 more sources
Emergency cesarean delivery in a parturient who had an intractable paroxysmal supraventricular tachycardia -A case report- [PDF]
Korean Journal of Anesthesiology, 2012 Paroxysmal supraventricular tachycardia (SVT) is a common arrhythmia in the parturient and can occur with or without an underlying organic heart disease.
Kyoung Ok Kim +3 more
doaj +1 more source
Patient-Specific Heart Model Towards Atrial Fibrillation [PDF]
ICCPS 2021: Proceedings of the ACM/IEEE 12th International
Conference on Cyber-Physical Systems, 2022 Atrial fibrillation is a heart rhythm disorder that affects tens of millions people worldwide. The most effective treatment is catheter ablation. This involves irreversible heating of abnormal cardiac tissue facilitated by electroanatomical mapping.
arxiv +1 more source
Fetal Tachyarrhythmia - Part I: Diagnosis [PDF]
, 2004 Fetal tachycardia, first recognized in 1930 by Hyman et al1, is a condition occurring in approximately 0.4-0.6% of all pregnancies2. A subset of these cases with more sustained periods of tachycardia is clinically relevant.
Meijboom, Erik J +2 more
core +8 more sources
Indian Pacing and Electrophysiology Journal, 2015 We report the case of a 46-year old patient in whom an electrophysiology study (EP) was performed due to paroxysmal supraventricular tachycardia documented in 12-lead ECG.
Ivan Zeljković +4 more
doaj +1 more source
Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia [PDF]
, 1987 Plasma immunoreactive atrial natriuretic factor was measured in 10 patients with chronic atrial fibrillation before and after cardioversion to sinus rhythm, and in 14 patients during electrophysiologic evaluation of paroxysmal supraventricular ...
Bourassa, Martial G. +6 more
core +1 more source
Long-term follow-up in paroxysmal atrial fibrillation patients with documented isolated trigger [PDF]
, 2023 Aims: Supraventricular tachycardias may trigger atrial fibrillation (AF). The aim of the study was to evaluate the prevalence of supraventricular tachycardia (SVT) inducibility in patients referred for AF ablation and to evaluate the effects of SVT ...
Borrelli, Alessio +12 more
core +1 more source
Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. [PDF]
, 2017 Aims: To conduct a randomized trial in order to guide the optimum therapy of symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT).
Camm, AJ +7 more
core +1 more source
The Response of Paroxysmal Supraventricular Tachycardia to Overdrive Atrial and Ventricular Pacing: [PDF]
, 1993 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75015/1/j.1540-8167.1993.tb01227.x ...
Almendral JM +20 more
core +1 more source